30 Grad visual field testFirst Therapy: July 2022 (Baseline Visual Field) |
|
|
Right eye |
Left eye |
.jpeg?width=640&height=580&name=Glaucoma%20vision%20improvement%20Fedorov%20Restore%20Vision%20Clinic10.24.08).jpeg) |
.jpeg?width=640&height=580&name=Glaucoma%20vision%20improvement%20Fedorov%20Restore%20Vision%20Clinic10.24.36).jpeg) |
|
At baseline, Khanh’s visual field showed severe defects in both eyes: - Improved awareness of her surroundings reduced her dependency on others for daily mobility. |
|
Second Therapy: June 2023 (11 Months After Baseline) |
|
|
Right eye |
Left eye |
.jpeg?width=640&height=580&name=Glaucoma%20vision%20improvement%20Fedorov%20Restore%20Vision%20Clinic10.23.50).jpeg) |
|
|
By the next evaluation, significant improvements were noted: |
Third Therapy: October 2024 (16 Months After Second Therapy)
|
Right eye |
Left eye |
|
|
|
By the final evaluation, stabilization was evident: |
Right Eye (RE) At baseline, the right eye demonstrated severe, widespread visual field defects, with extensive scotomas spanning both the central and peripheral regions. The functional visual field was critically impaired, with only fragmented areas of retained sensitivity. Over the evaluation period, incremental improvements were observed. Functional gains were most notable in the central visual field, accompanied by minor enhancements in the superior and inferior regions. Despite these improvements, large portions of the VF remain severely affected, with persistent scotomas limiting overall vision.
These findings suggest that the therapy provided a stabilizing effect, slowing the progression of glaucomatous damage while facilitating partial recovery of visual function. However, the remaining defects underline the advanced state of optic nerve damage in the right eye, which continues to impose significant limitations on the patient’s vision.
Left Eye (LE) The left eye presented with a similarly compromised visual field at baseline, characterized by diffuse loss and prominent blind spots. Both the central and peripheral regions were significantly affected, though the initial functional capacity was slightly better than the right eye. Over time, marked improvements were recorded, particularly in the central and inferior visual fields, which showed enhanced sensitivity and reduced defect density. The superior and peripheral areas, however, remained largely unchanged, reflecting the limitations of recovery in these regions. By the end of the observation period, the visual field in the left eye had stabilized, with no evidence of further deterioration.
These findings indicate a substantial therapeutic effect in the left eye, with notable recovery in key functional regions. The improvements align with expectations for glaucoma treatment, emphasizing the preservation of remaining vision and the stabilization of further decline.
At Fedorov Restore Vision Clinic, we believe that vision loss doesn’t have to define your future. Our clinic is internationally recognized for pioneering a groundbreaking approach to glaucoma treatment, offering hope to patients who have struggled with the limitations of traditional care.
Glaucoma is a progressive condition that causes damage to the optic nerve, often leading to irreversible vision loss. While conventional treatments typically focus on lowering intraocular pressure to slow the disease’s progression, they rarely address the possibility of restoring lost vision. That’s where our innovative approach sets us apart.
Our clinic specializes in advanced, non-invasive neuromodulation therapies designed to go beyond simply managing glaucoma. By stimulating the optic nerve and the brain’s visual pathways, we aim to slow the progression of the disease while reactivating dormant neurons. This groundbreaking technique holds the potential to restore lost visual function, enhancing clarity, field of vision, and contrast sensitivity. Each treatment plan is carefully tailored to meet the unique needs of our patients, ensuring the best possible outcomes.
Led by world-renowned specialists in vision restoration, Fedorov Restore Vision Clinic has become a trusted destination for those seeking more than traditional care. We are deeply committed to understanding every patient’s unique condition and delivering compassionate, effective treatment. Our patients often report significant improvements in their vision, providing renewed hope and a better quality of life.
“I have known Dr. Anton Fedorov for many years and his reputation as a specialist in field of vision restoration. He is pioneer in the area of non invasive electrical stimulation therapy. For more than 20 years, he has successfully used Restoration Therapy to help patients regain vision-loss from ‘untreatable’ conditions. We provide long lasting collaboration with him in regard to execute follow up evaluation for our mutual patients and help him exam his potential here in London if they can be qualified to receive treatment in Berlin Germany."
.jpeg?width=640&height=580&name=Glaucoma%20vision%20improvement%20Fedorov%20Restore%20Vision%20Clinic10.24.28).jpeg)
.jpeg?width=640&height=580&name=Glaucoma%20vision%20improvement%20Fedorov%20Restore%20Vision%20Clinic10.23.58).jpeg)
.jpeg?width=640&height=580&name=Glaucoma%20vision%20improvement%20Fedorov%20Restore%20Vision%20Clinic10.24.18).jpeg)